405 related articles for article (PubMed ID: 10471053)
1. Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Syrjänen K; Kosma VM
Br J Cancer; 1999 Aug; 80(12):2001-7. PubMed ID: 10471053
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
3. p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.
Ropponen KM; Kellokoski JK; Lipponen PK; Pietiläinen T; Eskelinen MJ; Alhava EM; Kosma VM
Br J Cancer; 1999 Sep; 81(1):133-40. PubMed ID: 10487624
[TBL] [Abstract][Full Text] [Related]
4. p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival.
Karjalainen JM; Eskelinen MJ; Kellokoski JK; Reinikainen M; Alhava EM; Kosma VM
Br J Cancer; 1999 Feb; 79(5-6):895-902. PubMed ID: 10070887
[TBL] [Abstract][Full Text] [Related]
5. Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression.
Baretton GB; Klenk U; Diebold J; Schmeller N; Löhrs U
Br J Cancer; 1999 May; 80(3-4):546-55. PubMed ID: 10408865
[TBL] [Abstract][Full Text] [Related]
6. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of p53 and p21(waf1/cip1) immunoreactivity in epithelial cancers of the ovary.
Werness BA; Freedman AN; Piver MS; Romero-Gutierrez M; Petrow E
Gynecol Oncol; 1999 Dec; 75(3):413-8. PubMed ID: 10600299
[TBL] [Abstract][Full Text] [Related]
9. Expression of cell-cycle regulatory proteins cyclin D1, cyclin E, and their inhibitor p21 WAF1/CIP1 in gastric cancer.
Müller W; Noguchi T; Wirtz HC; Hommel G; Gabbert HE
J Pathol; 1999 Oct; 189(2):186-93. PubMed ID: 10547573
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of p53, p21 (Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patients.
Hirai T; Kuwahara M; Yoshida K; Osaki A; Toge T
Anticancer Res; 1999; 19(5C):4587-91. PubMed ID: 10650815
[TBL] [Abstract][Full Text] [Related]
11. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer.
Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621
[TBL] [Abstract][Full Text] [Related]
13. High levels of constitutive WAF1/Cip1 protein are associated with chemoresistance in acute myelogenous leukemia.
Zhang W; Kornblau SM; Kobayashi T; Gambel A; Claxton D; Deisseroth AB
Clin Cancer Res; 1995 Sep; 1(9):1051-7. PubMed ID: 9816079
[TBL] [Abstract][Full Text] [Related]
14. p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer.
Anttila MA; Kosma VM; Hongxiu J; Puolakka J; Juhola M; Saarikoski S; Syrjänen K
Br J Cancer; 1999 Apr; 79(11-12):1870-8. PubMed ID: 10206307
[TBL] [Abstract][Full Text] [Related]
15. p21(WAF1) expression and endocrine response in breast cancer.
McClelland RA; Gee JM; O'Sullivan L; Barnes DM; Robertson JF; Ellis IO; Nicholson RI
J Pathol; 1999 Jun; 188(2):126-32. PubMed ID: 10398154
[TBL] [Abstract][Full Text] [Related]
16. Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas.
Shi YZ; Hui AM; Takayama T; Li X; Cui X; Makuuchi M
Br J Cancer; 2000 Jul; 83(1):50-5. PubMed ID: 10883667
[TBL] [Abstract][Full Text] [Related]
17. p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer.
Bennett WP; el-Deiry WS; Rush WL; Guinee DG; Freedman AN; Caporaso NE; Welsh JA; Jones RT; Borkowski A; Travis WD; Fleming MV; Trastek V; Pairolero PC; Tazelaar HD; Midthun D; Jett JR; Liotta LA; Harris CC
Clin Cancer Res; 1998 Jun; 4(6):1499-506. PubMed ID: 9626468
[TBL] [Abstract][Full Text] [Related]
18. p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinoma.
Schmider A; Gee C; Friedmann W; Lukas JJ; Press MF; Lichtenegger W; Reles A
Gynecol Oncol; 2000 May; 77(2):237-42. PubMed ID: 10785471
[TBL] [Abstract][Full Text] [Related]
19. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
[TBL] [Abstract][Full Text] [Related]
20. Expression of cell-cycle regulators, cyclin E and p21WAF1/CIP1, potential prognostic markers for gastric cancer.
Jang SJ; Park YW; Park MH; Lee JD; Lee YY; Jung TJ; Kim IS; Choi IY; Ki M; Choi BY; Ahn MJ
Eur J Surg Oncol; 1999 Apr; 25(2):157-63. PubMed ID: 10218458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]